Healthcare Infection Control Practices Advisory Committee (HICPAC), 59792 [2022-21406]
Download as PDF
<![CDATA[
59792
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Program Participant ..............
Chronic Disease Self-Management Workshop Evaluation.
Chronic Disease Self-Management Questionnaire (Pre-Post Test).
Program Participant ..............
Total ...............................
.......................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–21318 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (500 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on
November 3, 2022, from 12 p.m. to 2:30
p.m., EST.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
Please click the link below to join the
webinar: https://cdc.zoomgov.com/j/
1618328215?pwd=NWx1cGZGS3Y0THd
zS1RraHBpZFNZZz09.
Meeting ID: 161 832 8215.
Passcode: 76683972.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
21:31 Sep 30, 2022
Jkt 259001
1
10/60
32
190
2
10/60
63
........................
........................
........................
95
Public Participation
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
Written Public Comment: The public
may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is October 24, 2022. All
requests must contain the submitter’s
name, address, and organizational
affiliation, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
Frm 00023
Fmt 4703
Total burden
(in hr)
190
Georgia 30329–4027, Telephone: (404)
718–8039; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, DHQP; the Director,
NCEZID; the Director, CDC; and the
Secretary, Department of Health and
Human Services, regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; Neonatal
Intensive Care Unit Guideline
Workgroup; Neonatal Pediatric
Surveillance Workgroup; and Dental
Unit Waterlines Guideline Update.
Agenda items are subject to change as
priorities dictate.
PO 00000
Average
burden per
response
(in hr)
Number of
responses per
respondent
Number of
respondents
Type of respondent
Sfmt 4703
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–21406 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3424–CN]
Medicare and Medicaid Programs:
Approval of Application From Det
Norske Veritas for Continued Hospital
Accreditation Program; Correction
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice; correction.
AGENCY:
This document corrects a
technical error that appeared in the final
notice published in the Federal Register
on September 6, 2022, entitled
‘‘Approval of Application From Det
Norske Veritas for Continued Hospital
Accreditation Program.’’
Effective date: This correction is
effective October 3, 2022.
Applicability date: The decision
announced in the final notice is
effective through September 26, 2026.
FOR FURTHER INFORMATION CONTACT: Joy
Webb, (410) 786–1667 or Lillian
Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\03OCN1.SGM
03OCN1
]]>Agencies
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Page 59792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21406]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by the number of audio and web conference
lines (500 audio and web conference lines are available). Time will be
available for public comment. Registration is required.
DATES: The meeting will be held on November 3, 2022, from 12 p.m. to
2:30 p.m., EST.
ADDRESSES: To register for this web conference, please go to:
www.cdc.gov/hicpac. All registered participants will receive the
meeting link and instructions shortly before the meeting. Please click
the link below to join the webinar: https://cdc.zoomgov.com/j/1618328215?pwd=NWx1cGZGS3Y0THdzS1RraHBpZFNZZz09.
Meeting ID: 161 832 8215.
Passcode: 76683972.
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC,
1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027,
Telephone: (404) 718-8039; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, DHQP; the Director, NCEZID; the Director,
CDC; and the Secretary, Department of Health and Human Services,
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; Isolation
Precautions Guideline Workgroup; Neonatal Intensive Care Unit Guideline
Workgroup; Neonatal Pediatric Surveillance Workgroup; and Dental Unit
Waterlines Guideline Update. Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public may submit written comments in
advance of the meeting. Comments should be submitted in writing by
email to the contact person listed above. The deadline for receipt of
written public comment is October 24, 2022. All requests must contain
the submitter's name, address, and organizational affiliation, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length. Written comments received in
advance of the meeting will be included in the official record of the
meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-21406 Filed 9-30-22; 8:45 am]
BILLING CODE 4163-18-P
